Houston biotech firm adds C-suite roles, opens new research lab in TMC
July 28, 2021 at 18:41 PM EDT
ImmunoGenesis is focused on developing a pipeline of therapies aimed at tumors that have resisted other immunotherapies.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|